Business
Entheon Announces Letter of Intent with Nutravisor Inc.
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered into a binding Letter of Intent (the "LOI") dated December 18, 2025, with Nutravisor Inc. ("Nutravisor") whereby Entheon will acquire all of the issued and outstanding common shares of Nutravisor (the "Proposed Transaction"). Upon completion of the Proposed Transaction, the combined entity will..
About this update from Entheon Biomedical Corp.
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered into a binding Letter of Intent (the "LOI") dated December 18, 2025, with Nutravisor Inc. ("Nutravisor") whereby Entheon will acquire all of the issued and outstanding common shares of Nutravisor (the "Proposed Transaction"). Upon completion of the Proposed Transaction, the combined entity will continue the business of Nutravisor (the "Resulting Issuer").","length":620,"tagName":"p"},{"type":"text","content":""Nutravisor is thrilled to move forward with this transaction. The successful completion of Proposed Transaction is expected to help Nutravisor achieve its goal in becoming a global leader in providing consumers with pouch and nutraceutical products," said Max Krangle, CEO of Nutravisor.","length":298,"tagName":"p"},{"type":"text","content":""We see this transaction is an excellent opportunity for the ENBI shareholders and look forward to a bright future with Nutravisor," said Timothy Ko, CEO of Entheon.","length":175,"tagName":"p"},{"type":"text","content":"Transaction Terms","length":17,"tagName":"p"},{"type":"text","content":"The Proposed Transaction is expected to be completed by way of a share exchange, merger, amalgamation, arrangement or other similar form of transaction whereby the shareholders of Nutravisor will receive common shares in the capital of the Entheon in exchange for their shares in the capital of Nutravisor. The final structure and form of the Proposed Transaction remains subject to satisfactory tax, corporate and securities law advice for both Entheon and Nutravisor and will be set forth in a definitive agreement (the "Definitive Agreement") to be entered into among the parties.","length":593,"tagName":"p"},{"type":"text","content":"Under the terms of the LOI, Entheon has agreed to issue an aggregate of 53,333,333 shares of Entheon to existing shareholders of Nutravisor at a per share price equal to $0.75 for aggregate consideration equal to approximately $40,000,000 on a post-consolidation basis. Entheon shall be required to complete an approximately 6.93:1 share consolidation such that the value allocated to Ent...